You are here

BetterLife Pharma Inc.

BetterLife Pharma  Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
BETR
CSE Index: 
Currency: 

BetterLife Pharma Inc. ("BetterLife") is an emerging biotechnology company primarily focused on developing and commercializing two compounds, TD-0148A and TD-010, to treat neurological disorders such as depression, cluster headaches and anxiety. TD-0148A is a non-hallucinogenic and non-controlled psychedelic candidate and is unique in that it is not regulated and therefore can be self-administered. TD-010 is a treatment of anxiety without the addictive potential of benzodiazepines. BetterLife also owns a drug candidate for the treatment of viral infections such as COVID-19 and is in the process of seeking strategic alternatives for further development.

You are here

BetterLife Pharma Inc. (BETR)

SEDAR Information

Company Info

Address
300 - 1275 West 6th Avenue
Vancouver, BC V6H 1A6
Canada
Fax
604-738-7134
Email
info@blifepharma.com
Website
https://abetterlifepharma.com/
Listing date
Tuesday, December 19, 2017
Transfer Agent
National Securities Administrators Ltd.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
84,824,172
Reserved for Issuance: 
39,397,186

Bulletins

31/08/2020

2020-0836 – Fundamental Change - BetterLife Pharma Inc. (BETR)

Le 31 aout/August 2020

Following a fundamental change review the common shares of BetterLife Pharma Inc. have requalified for listing.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News